JPRN-UMIN000029534
Completed
未知
Study of patient risk factors for febrile neutropenia in NHL receiving (R)CHOP regimen 2 - STOP FN in NHL 2
The Cancer Institute Hospital Of JFCR0 sites239 target enrollmentOctober 13, 2017
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- on Hodgkin'
- Sponsor
- The Cancer Institute Hospital Of JFCR
- Enrollment
- 239
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Refer to the article
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •HIV related NH
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Study Of Patient risk factors for Febrile Neutropenia in NHL patients receiving (R)CHOP regimeon Hodgkin's LymphomaJPRN-UMIN000015121The Cancer Institute Hospital Of JFCR400
Recruiting
Not Applicable
IL-8 study.- Pediatric cancer patients- Febrile neutropenia- Risk assessment model- Antibiotic treatmentNL-OMON21368niversity Medical Center of GroningenHanzeplein 19713 GZ Groningen270
Completed
Not Applicable
Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.Chemotherapy-induced Febrile NeutropeniaNCT01813721Amgen1,007
Completed
Not Applicable
A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic ChemotherapyBreast CancerNon-Small Cell Lung CancerOvarian CancerSmall Cell Lung CancerNCT00883181Amgen1,370
Completed
Not Applicable
Hematologic Toxicity Observation of the Docetaxel+ Cisplatin+ Fluorouracil (TPF)Medical ProtocolSquamous Cell Head and Neck CarcinomaNCT01268878Groupe Oncologie Radiotherapie Tete et Cou130